The peptide's stability profile allows for both oral and parenteral administration, with documented biological activity through multiple delivery routes including subcutaneous, intramuscular, intraperitoneal, and oral administration
Retatrutide is the lead compound the term is associated with
Additionally, intraperitoneal administration of GLP-1 at supraphysiological doses elicited an anti-adipogenic effect in rats (72), making GLP-1 a potential target for obesity treatment
Over subsequent months, the weight loss mechanism compounds this effect, potentially requiring further dose adjustments as body weight decreases
[11] [14] It has been used to treat lactobezoar in infants
The legitimate ones use a named, licensed prescriber and a disclosed compounding pharmacy, and only sell currently legal peptides